介绍:
慢速新闻口译33天第20天
该计划创建于1992年，目的是加快艾滋病药物的审批速度。
如今，大约85%的加速审批流向了抗癌药物。
该计划帮助FDA收集有关批准药物的早期结果的数据。
作为交换，制药公司预计将使用这些数据进行额外的测试。
English Version of Special English News Day 19
A new study has found that 41 percent of cancer drugs receiving accelerated government approval do not improve survival or quality of life.
The U.S. Food and Drug Administration's (FDA's) accelerated approval program aims to get new drugs to patients as quickly as possible. But the effectiveness of the drugs differs.
大家还在听
